<Suppliers Price>

Burfiralimab

Names

[ CAS No. ]:
2460809-80-5

[ Name ]:
Burfiralimab

Biological Activity

[Description]:

Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies[1].

[Related Catalog]:

Research Areas >> Infection
Signaling Pathways >> Immunology/Inflammation >> Interleukin Related
Signaling Pathways >> Anti-infection >> SARS-CoV
Research Areas >> Inflammation/Immunology

[References]

[1]. Prasenohadi Prasenohadi, et al. Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19. J Clin Med. 2022 May 24;11(11):2961.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds